Viridian Therapeutics, Inc.\DE Quarterly Interest Expense in USD from Q2 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Viridian Therapeutics, Inc.\DE quarterly/annual Interest Expense history and growth rate from Q2 2013 to Q2 2023.
  • Viridian Therapeutics, Inc.\DE Interest Expense for the quarter ending June 30, 2023 was $200K, unchanged year-over-year.
  • Viridian Therapeutics, Inc.\DE Interest Expense for the twelve months ending June 30, 2023 was $700K.
  • Viridian Therapeutics, Inc.\DE annual Interest Expense for 2022 was $500K.
  • Viridian Therapeutics, Inc.\DE annual Interest Expense for 2016 was $95K, a 32.6% decline from 2015.
  • Viridian Therapeutics, Inc.\DE annual Interest Expense for 2015 was $141K, a 86.2% decline from 2014.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $700K $200K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $700K $200K +$200K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $500K $100K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-09
Q3 2022 $200K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $200K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2016 $95K $26K +$3K +13% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-24
Q3 2016 $92K $23K -$1K -4.17% Jul 1, 2016 Sep 30, 2016 10-Q 2016-10-26
Q2 2016 $93K $23K -$49K -68.1% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $142K $23K +$1K +4.55% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-16
Q4 2015 $141K $23K +$21K +1050% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 $120K $24K +$20K +500% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-26
Q2 2015 $100K $72K -$406K -84.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $506K $22K -$517K -95.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $1.02M $2K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-21
Q3 2014 $4K -$564K -99.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $478K -$1.32K -0.28% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $539K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 $568K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $479K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.